{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T19:01:51Z","timestamp":1761764511964,"version":"build-2065373602"},"reference-count":27,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2005,7,24]],"date-time":"2005-07-24T00:00:00Z","timestamp":1122163200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["bjui-journals.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["BJU International"],"published-print":{"date-parts":[[2005,8]]},"abstract":"<jats:sec>\n                    <jats:title>OBJECTIVE<\/jats:title>\n                    <jats:p>To assess the effect of antimuscarinic treatment with tolterodine combined with behavioural modification as a first\u2010line treatment, before invasive investigation, in children with non\u2010neurogenic voiding dysfunction but no obvious anatomical or neurogenic cause.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>PATIENTS AND METHODS<\/jats:title>\n                    <jats:p>The study comprised 44 children presenting with voiding dysfunction (30 girls and 14 boys, mean age 7\u2003years, range 5\u201314); all had a noninvasive evaluation consisting of a history, urine analysis, renal and bladder ultrasonography and physical examination, with specific emphasis on the voiding pattern. Anticholinergic treatment with tolterodine (1\u2003mg twice daily) was started in all patients; they were also informed about conservative management, including timed voiding, double voiding and relaxation of the pelvic floor during voiding. At the start and after 3\u2003months, the dysfunctional voiding symptom score (DVSS) was completed twice by all patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS<\/jats:title>\n                    <jats:p>\n                      For all patients the mean (\n                      <jats:sc>sd<\/jats:sc>\n                      ) DVSS was 14.0\u2003(2.67) and 6.68\u2003(3.67) before and after treatment, respectively; the difference was statistically significant (\n                      <jats:italic>P<\/jats:italic>\n                      \u2003&lt;\u20030.001). The mean scores for girls and boys, respectively, were 13.8\u2003(2.79) and 14.5\u2003(2.44) before and 6.43\u2003(3.79) and 7.50\u2003(3.34) after treatment.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSION<\/jats:title>\n                    <jats:p>Tolterodine combined with behavioural modification for dysfunctional voiding in children with no neurological or anatomical abnormality can be recommended as a first\u2010line treatment before invasive evaluation. Additionally, the DVSS appears to provide accurate and objective data for monitoring the effect of treatment in such children.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/j.1464-410x.2005.05641.x","type":"journal-article","created":{"date-parts":[[2005,7,24]],"date-time":"2005-07-24T13:35:28Z","timestamp":1122212128000},"page":"411-414","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Efficacy of tolterodine as a first\u2010line treatment for non\u2010neurogenic voiding dysfunction in children"],"prefix":"10.1111","volume":"96","author":[{"given":"Semih","family":"Ayan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kemal","family":"Kaya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kahraman","family":"Topsakal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hakan","family":"Kilicarslan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gokhan","family":"Gokce","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yener","family":"Gultekin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2005,7,24]]},"reference":[{"key":"e_1_2_7_2_2","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0094-0143(21)01018-1","article-title":"Wetting and functional disorders","volume":"22","author":"Rushton HG","year":"1995","journal-title":"Urol Clin North Am"},{"key":"e_1_2_7_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/0090-4295(91)80148-Z"},{"key":"e_1_2_7_4_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1464-410x.1998.00025.x"},{"key":"e_1_2_7_5_2","first-page":"58","article-title":"Functional daytime incontinence: clinical and urodynamic assessment","volume":"141","author":"Van Gool JD","year":"1992","journal-title":"Scand J Urol Nephrol Suppl"},{"key":"e_1_2_7_6_2","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1016\/S0022-5347(17)37006-4","article-title":"Historical clues to the complex of dysfunctional voiding, urinary tract infection and vesicoureteral reflux. International Reflux Study in Children","volume":"148","author":"Van Gool JD","year":"1992","journal-title":"J Urol"},{"key":"e_1_2_7_7_2","doi-asserted-by":"publisher","DOI":"10.1542\/peds.103.3.e31"},{"key":"e_1_2_7_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(05)66576-7"},{"key":"e_1_2_7_9_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1464-410X.2001.00084.x"},{"key":"e_1_2_7_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.urology.2003.11.004"},{"key":"e_1_2_7_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2003.10.009"},{"key":"e_1_2_7_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0090-4295(99)00477-X"},{"key":"e_1_2_7_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(05)67239-4"},{"key":"e_1_2_7_14_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1464-410X.1997.00447.x"},{"key":"e_1_2_7_15_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1464-410X.2001.00083.x"},{"key":"e_1_2_7_16_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005392-200101000-00061"},{"key":"e_1_2_7_17_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-410X.2003.04734.x"},{"key":"e_1_2_7_18_2","unstructured":"HjalmasK Hellstr\u00f6mAL MogrenKet al.Safety efficacy and pharmacokinetics of tolterodine in pediatric patients with overactive bladder.Invited lecture of 2nd Congress of the ICSS Denver:August 1999"},{"key":"e_1_2_7_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(01)62686-7"},{"key":"e_1_2_7_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(05)67313-2"},{"key":"e_1_2_7_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(01)62425-X"},{"key":"e_1_2_7_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0094-0143(05)70329-3"},{"key":"e_1_2_7_23_2","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/S0022-5347(17)63782-0","article-title":"Distal urethral stenosis in little girls","volume":"93","author":"Lyon RP","year":"1965","journal-title":"J Urol"},{"key":"e_1_2_7_24_2","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1016\/S0022-5347(17)61210-2","article-title":"Urinary tract infection in children. fact and fantasy","volume":"107","author":"Kendall AR","year":"1972","journal-title":"J Urol"},{"key":"e_1_2_7_25_2","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/S0022-5347(17)63100-8","article-title":"The urethral caliber in normal female children","volume":"97","author":"Immergut M","year":"1967","journal-title":"J Urol"},{"key":"e_1_2_7_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(17)61582-9"},{"key":"e_1_2_7_27_2","first-page":"1401","article-title":"Reliability of the pediatric dysfunctional voiding symptom score in monitoring response to behavioral modification","volume":"8","author":"Farhat W","year":"2001","journal-title":"Can J Urol"},{"key":"e_1_2_7_28_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.ju.0000058211.24641.66"}],"container-title":["BJU International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1464-410X.2005.05641.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/bjui-journals.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1464-410X.2005.05641.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T17:20:11Z","timestamp":1761758411000},"score":1,"resource":{"primary":{"URL":"https:\/\/bjui-journals.onlinelibrary.wiley.com\/doi\/10.1111\/j.1464-410X.2005.05641.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,7,24]]},"references-count":27,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2005,8]]}},"alternative-id":["10.1111\/j.1464-410X.2005.05641.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1464-410x.2005.05641.x","archive":["Portico"],"relation":{},"ISSN":["1464-4096","1464-410X"],"issn-type":[{"type":"print","value":"1464-4096"},{"type":"electronic","value":"1464-410X"}],"subject":[],"published":{"date-parts":[[2005,7,24]]},"assertion":[{"value":"2005-07-24","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}